Why this is the most powerful intervention to reduce CV mortality

Glycaemic control is not the only priority for type 2 diabetes

sponsored

Content produced by Australian Doctor Group with an independent educational grant from Boehringer Ingelheim Pty Limited and Eli Lilly Australia Pty Limited.